A multi-center single arm phase II study of MDX-010 (BMS-734016) monotherapy in patients with previously treated unresectable stage III or IV melanoma

Status: Completed

Phase of Trial: Phase II

Latest Information Update: 12 Jan 2022

Price :

Note:

Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.

01 Jun 2009 Two-year survival data was presented at the 45th Annual Meeting of the American Society of Clinical Oncology (ASCO), according to a Bristol-Myers Squibb media release.
12 Sep 2008 Updated one-year survival data will be presented at the 33rd Congress of the European Society for Medical Oncology in September.
03 Jun 2008 Results presented at ASCO 2008.

If your organization or you do not have a subscription, try one of the following:

Contacting your organization’s admin about adding this content to your AdisInsight subscription
Buying a PDF version of any individual profile
Request a free trial

If your organization has a subscription, there are several access options, even while working remotely:

Working within your organization’s network
Login with username/password or try to access via your institution
Persisted access using your organization’s identifier stored in your user browser for 90 days

For assistance, contact us at asktheexpert.adisinsight@springer.com